Douglas Jones (physician)
Douglas H. Jones | |
|---|---|
| Education | University of Utah (BA) Penn State University College of Medicine (MD) |
| Office | Global Food Initiative (GFI) |
| Medical career | |
| Profession | allergist, immunologist |
| Institutions | Tanner Clinic |
| Sub-specialties | allergology, immunology |
| Research | food allergy |
Douglas H. Jones is an American and Australian allergist and immunologist. He is a co-founder of the Global Food Initiative (GFI).[1]
Education and career[edit]
Douglas Jones earned his BA in Biology with minors in Chemistry, Math, and Korean from the University of Utah in 1999 and his MD degree from the Penn State University College of Medicine in 2003. He attended the internal medicine program at Creighton University Medical Center from 2003 to 2006. He was a research fellow in Allergy, Asthma, and Immunology from 2006 to 2008 at the same university.
Jones devoted himself to allergy, asthma, and immunology research. He is the co-founder of the Sydney-based The Immunity Group and a journal Allergies, Immunity & Microbiome News.[2]
He is a member of the American Medical Association, Australasian Society of Clinical Immunology and Allergy, and the European Academy of Allergy and Clinical Immunology.
Publications[edit]
Book[edit]
- The Immune Fitness Project – Food Allergy Resilience (Immunity Group Australia, 2023), with Nina Marković-Khaze[3]
Selected articles[edit]
- Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome (Journal of American Osteopathic Association, 2004), with Michael Todd and Timothy J. Craig[4]
- Regression of colorectal adenomas with intravenous cytotoxic chemotherapy in a patient with familial adenomatous polyposis (Journal of Clinical Oncology, 2005), with Peter T. Silberstein, Henry Lynch, Charles Ternet[5]
- Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine (Annals of Allergy, Asthma, and Immunology, 2008), with Francisco A. Romero, Thomas B. Casale[6]
- Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor (Annals of Allergy, Asthma, and Immunology, 2022), et al.[7]
- Oral immunotherapy for food allergy: The FAST perspective (Ann Allergy Asthma Immunol, 2018), with Richard L. Wasserman, Hugh H. Windom[8]
- Oral immunotherapy in US allergy practice (J Allergy Clin Immunol Pract, 2023), with Richard L. Wasserman, Hugh H. Windom[9]
Selected awards and honors[edit]
 |
- America's Top Physicians (2011–2013)
- Who's Who Among America's Top Doctors (2012
- Who's Who Top Doctors Honors Edition (2016–2024)
- America's Most Honored Doctors (2022–2024)
- APEX Award for Publication Excellence (2023)
References[edit]
- ^ About the Global Food Initiative, Spacial Health.
- ^ Allergies, Immunity & Microbiome News, No. 1, eDijaspora, 2023.
- ^ Jones, D.; Marković Khaze, Nina. (2023). The Immune Fitness Project – Food Allergy Resilience. Sidney: Immunity Group Australia. ISBN 978-0-645-9793-0-5.
- ^ "Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome", Journal of American Osteopathic Association, 2004.
- ^ "Regression of colorectal adenomas with intravenous cytotoxic chemotherapy in a patient with familial adenomatous polyposis", Journal of Clinical Oncology, 2005.
- ^ "Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine", Annals of Allergy, Asthma, and Immunology, 2008.
- ^ "Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor", Annals of Allergy, Asthma, and Immunology, 2022.
- ^ "Oral immunotherapy for food allergy: The FAST perspective", Ann Allergy Asthma Immunol, 2018.
- ^ Oral immunotherapy in US allergy practice", J Allergy Clin Immunol Pract, 2023.
